BlueSky Medical Group, Inc., a prominent player in the healthcare industry, is headquartered in the United States and operates extensively across various regions. Founded in [year], the company has established itself as a leader in providing innovative medical solutions, focusing on [specific areas of expertise, e.g., telemedicine, patient management systems]. With a commitment to enhancing patient care, BlueSky Medical Group offers a range of unique services, including [core products/services], which distinguish it from competitors. The company has achieved significant milestones, solidifying its market position through [notable achievements or recognitions]. As a trusted name in the medical sector, BlueSky Medical Group continues to drive advancements in healthcare, ensuring quality and accessibility for patients nationwide.
How does BlueSky Medical Group, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
BlueSky Medical Group, Inc.'s score of 52 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
BlueSky Medical Group, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Smith & Nephew plc, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from BlueSky Medical Group, it is important to note that emissions data and performance metrics may be inherited from its parent company, Smith & Nephew plc. This relationship suggests that any climate initiatives or targets may align with those set by Smith & Nephew, although specific details are not provided. As a subsidiary, BlueSky Medical Group's climate strategy may be informed by industry standards and practices established by its parent organisation, which is committed to sustainability and reducing its environmental impact. However, without specific emissions data or reduction targets, it is challenging to assess the company's individual climate commitments at this time.
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 10,123,000 | 00,000,000 | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
| Scope 2 | 67,559,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 
| Scope 3 | - | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 
BlueSky Medical Group, Inc.'s Scope 3 emissions, which decreased by 48% last year and decreased by approximately 59% since 2021, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 73% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BlueSky Medical Group, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.